Comment on Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.
作者信息
Topkan Erkan, Somay Efsun, Selek Ugur
机构信息
Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey.
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey.
出版信息
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):367-368. doi: 10.31557/APJCP.2024.25.2.367.
Abstract
摘要
相似文献
1
Comment on Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.关于比较常规放化疗与超分割放化疗治疗局部晚期口咽癌疗效的前瞻性研究述评
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):367-368. doi: 10.31557/APJCP.2024.25.2.367.
2
Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.前瞻性研究比较常规放化疗与低分割放化疗治疗局部晚期口咽癌的疗效。
Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4077-4083. doi: 10.31557/APJCP.2023.24.12.4077.
3
Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.小体积原发性口咽癌的微创手术与放疗/放化疗对比
Cochrane Database Syst Rev. 2016 Dec 11;12(12):CD010963. doi: 10.1002/14651858.CD010963.pub2.
4
Chemoradiotherapy for locally advanced squamous cell carcinoma of the oropharynx: Does completion of systemic therapy affect outcomes?同期放化疗治疗局部晚期口咽鳞癌：系统治疗完成情况是否影响疗效？
Oral Oncol. 2017 Oct;73:105-110. doi: 10.1016/j.oraloncology.2017.08.015.
5
DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity.DAHANCA 28 研究：同期顺铂和尼莫佐胺增敏超分割加速放疗（HART-CN）治疗 HPV/p16 阴性局部晚期口咽、下咽、喉及口腔鳞癌的 I/II 期可行性研究。
Radiother Oncol. 2020 Jul;148:65-72. doi: 10.1016/j.radonc.2020.03.025. Epub 2020 Mar 28.
6
Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer.序贯化放疗联合加速超分割放疗对比同期化放疗联合标准放疗治疗局部晚期非小细胞肺癌。
Technol Cancer Res Treat. 2014 Jun;13(3):269-75. doi: 10.7785/tcrt.2012.500375. Epub 2013 Sep 20.
7
Different clinical outcomes between locally advanced hypopharyngeal and oropharyngeal cancer treated with definitive concurrent chemoradiotherapy: implication for subgroup selection for induction chemotherapy.局部晚期下咽癌和口咽癌采用根治性同步放化疗的不同临床结局：对诱导化疗亚组选择的启示
Jpn J Clin Oncol. 2016 Jan;46(1):40-5. doi: 10.1093/jjco/hyv163. Epub 2015 Nov 10.
8
Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas.研究方案：S-1同步放化疗与超分割放疗治疗早期声门鳞状细胞癌门诊患者的前瞻性研究
Asian Pac J Cancer Prev. 2018 May 26;19(5):1195-1199. doi: 10.22034/APJCP.2018.19.5.1195.
9
High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.高剂量加速超分割三维适形放疗（每次 3 Gy）联合长春瑞滨和顺铂化疗治疗局部晚期非小细胞肺癌：一项可行性研究。
Radiat Oncol. 2013 Aug 11;8(1):198. doi: 10.1186/1748-717X-8-198.
10
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.帕尼单抗联合放疗对比放化疗用于治疗不可切除的局部晚期头颈部鳞状细胞癌患者（CONCERT-2）：一项随机、对照、开放标签的 2 期临床试验。
Lancet Oncol. 2015 Feb;16(2):221-32. doi: 10.1016/S1470-2045(14)71200-8. Epub 2015 Jan 15.
本文引用的文献
1
Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.前瞻性研究比较常规放化疗与低分割放化疗治疗局部晚期口咽癌的疗效。
Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4077-4083. doi: 10.31557/APJCP.2023.24.12.4077.
2
Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors.颌骨放射性骨坏死综述：放疗方式、技术及剂量作为风险因素
J Clin Med. 2023 Apr 21;12(8):3025. doi: 10.3390/jcm12083025.
3
Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients.放化疗前低血红蛋白水平提示局部晚期鼻咽癌患者发生骨放射性坏死的风险增加。
Eur Arch Otorhinolaryngol. 2023 May;280(5):2575-2584. doi: 10.1007/s00405-023-07864-7. Epub 2023 Feb 7.
4
Oral Equilibrium in Cachexia.恶病质中的口腔平衡
Asia Pac J Oncol Nurs. 2021 Aug 27;8(5):519-526. doi: 10.4103/apjon.apjon-2139. eCollection 2021 Sep-Oct.
5
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.长期口咽癌幸存者患者报告的口干症决定因素。
Cancer. 2021 Dec 1;127(23):4470-4480. doi: 10.1002/cncr.33849. Epub 2021 Aug 6.
6
Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer.放疗所致毒性反应对接受头颈癌治疗患者生活质量的影响。
Radiother Oncol. 2021 Jul;160:47-53. doi: 10.1016/j.radonc.2021.04.011. Epub 2021 Apr 20.
7
Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.调强放射治疗与二维放疗或三维适形放疗治疗鼻咽癌的系统评价和荟萃分析
Oral Oncol. 2015 Nov;51(11):1041-1046. doi: 10.1016/j.oraloncology.2015.08.005. Epub 2015 Aug 18.
8
Health-related quality of life and cancer clinical trials.健康相关生活质量与癌症临床试验。
Ther Adv Med Oncol. 2011 Mar;3(2):57-71. doi: 10.1177/1758834010395342.
9
Radiotherapy and oral sequelae: preventive and management protocols.放射治疗与口腔后遗症：预防及管理方案
J Dent Hyg. 1997 Jan-Feb;71(1):23-9.
Zotero 插件